limited disease small cell lung cancer
Conditions
Interventions
csiplatin, etoposide, thoratic radiation
Sponsors
Department of Medical Oncology, Kinki University faculty of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) SCLC 2) No prior treatment 3) limited disease SCLC 4) age>=70 years,Performance status (PS) of 0 to 1 5) At least one measurable lesion 6) Adequate main organ functions 7) Written informed consent
Exclusion criteria
Exclusion criteria: 1)Severe infection and complication (hemorrhage and heart disease etc.) 2)Intestinal pneumonia or lung fibrosis 3)History of severe drug allergic reaction 4)Pregnant women or women willing child bearing 5)Men willing to have children 6)Uncontrolled diabetes 7)Uncontrolled pleural, cardiac, or abdominal effusion 8)Fever over 38 degrees Celsius 9)History of thoratic radiation 10)Inadequate condition diagnosed by primary physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To estimate recommended split dose of cisplatin and etoposide with early concurrent accelerated hyperfractionated thoracic radiotherapy in elderly patients with limited disease small cell lung cancer | — |
Countries
Japan
Outcome results
None listed